Edition:
India

People: Extendicare Inc (EXE.TO)

EXE.TO on Toronto Stock Exchange

8.49CAD
1:30am IST
Change (% chg)

$-0.16 (-1.85%)
Prev Close
$8.65
Open
$8.65
Day's High
$8.65
Day's Low
$8.45
Volume
171,835
Avg. Vol
174,823
52-wk High
$10.45
52-wk Low
$8.12

Torrie, Alan 

Mr. Alan D. Torrie is Independent Chairman of the Board of the Company. Mr. Torrie has been the President and Chief Executive Officer of Morneau Shepell Ltd. (Morneau Shepell) since 2008, and a member of its board of directors since 2005. He plans to retire from Morneau Shepell at its annual meeting in May 2017 and, as announced, is expected to succeed Mr. Hutzel as Chairman of the Board immediately following the Meeting. Morneau Shepell, a TSX listed company, is a leading provider of Employee and Family Assistance Programs, the largest administrator of pension and benefits plans and the largest provider of integrated absence management solutions in Canada. Mr. Torrie has over 30 years of experience as a senior executive leader in the seniors’ housing and health and science industries, including as Chief Operating Officer of RRR from 2005 to 2007, before it was taken private as Revera Inc., and in a number of senior executive positions at MDS Inc. (a predecessor of Nordion Inc.) from 1987 to 2005, where he served as Executive Vice President of MDS Inc. (2003 – 2005), and as President and Chief Executive Officer of MDS Diagnostics and MDS Laboratories (1999 – 2003). He has also served as Executive-inResidence with Clairvest Private Equity, a Toronto-based private equity management firm, and earlier in his career as the President and CEO of Joseph Brant Hospital and Chief Operating Officer and Vice President of Humber Memorial Hospital. Mr. Torrie has served on numerous community boards, and is currently a director and Chairman of the Finance Committee of Appleby College. In addition, he is past Chair of Trillium Health Partners and previously served on the board of Cynapsus Therapeutics and as a member of its Audit Committee. Mr. Torrie holds a B.Sc in Biochemistry from McMaster University, a DHA in Healthcare Management from the University of Toronto and has completed the Advanced Management Program from Harvard University.

Basic Compensation

Total Annual Compensation, CAD 53,125
Restricted Stock Award, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD 50,000
Fiscal Year Total, CAD 103,125

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alan Torrie

103,125

Timothy Lukenda

2,499,390

Elaine Everson

640,478

Deborah Bakti

329,186

Michael Harris

344,402

Jillian Fountain

364,168
As Of  31 Dec 2016